Zanolimumab (HuMax-CD4®), a fully human monoclonal antibody in clinical development for cutaneous T-cell lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 23 [cited 2026 Apr. 22];2(5). Available from: https://journals.pagepress.net/hmr/article/view/736